Anders Ekblom

Insider Reports History

Location
London, United Kingdom
Signature
/s/ Christine Fox, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anders Ekblom:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mereo BioPharma Group plc Director Share Options (Right to buy) 66,000 $55,550 $1.01 26 Feb 2026 Direct
Mereo BioPharma Group plc Director Deferred Restricted Stock Units 133,560 26 Feb 2026 Direct

Insider Reports Filed by Anders Ekblom

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MREO Mereo BioPharma Group plc 26 Feb 2026 2 $0 4 Director 27 Feb 2026, 16:30
MREO Mereo BioPharma Group plc 05 Feb 2025 2 $0 4 Director 06 Feb 2025, 16:30
MREO Mereo BioPharma Group plc 08 Feb 2024 2 $0 4 Director 09 Feb 2024, 16:15
MREO Mereo Biopharma Group plc 01 Jan 2024 0 $0 3 Director 02 Jan 2024, 16:20